National Institute Of Cardiovascular Diseases, Pakistan
Clinical trials sponsored by National Institute Of Cardiovascular Diseases, Pakistan, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a special diet before heart surgery cut the need for blood transfusions? Results expected May 2027 (estimated)
- Heart failure drug aims to boost daily living and cut hospital visits Results expected May 2027 (estimated)
- Heart rate drug may speed recovery from shock after heart attack Results expected May 2027 (estimated)
-
Clot-Sucking catheter may boost heart attack outcomes
Disease control OngoingThis study compares using a manual clot-removal catheter (Export) before standard balloon angioplasty versus angioplasty alone in 300 heart attack patients with completely blocked arteries. The goal is to see if removing the clot first improves blood flow and reduces in-hospital …
Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Heart bypass study tests best way to close leg wounds
Knowledge-focused By invitation onlyThis study compares two methods of closing the leg incision after taking a vein for heart bypass surgery: a single-layer stitch versus a multi-layer stitch. Researchers will track 200 patients for one week to see which method leads to fewer wound infections, hematomas, or other c…
Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC